WHO ICTRP trial
Exploratory study of Transarterial Chemoembolization (TACE) combined with…
ChiCTR-OPC-15006703 · Chinese Clinical Trial Registry (ChiCTR) · Not Recruiting
Key facts
| Trial ID | ChiCTR-OPC-15006703 |
|---|---|
| Public title | Exploratory study of Transarterial Chemoembolization (TACE) combined with immunotherapy in the treatment of middle or advanced Stage hepatocellular Carcinoma(HCC) |
| Scientific title | Exploratory study of Transarterial Chemoembolization (TACE) combined with immunotherapy in the treatment of middle or advanced Stage hepatocellular Carcinoma(HCC) |
| Primary sponsor | Gastrointestinal surgery,Fujian Provincial Cancer Hospital |
| Registry | Chinese Clinical Trial Registry (ChiCTR) |
| Recruitment status | Not Recruiting |
| Study type | Observational study |
| Phase | II (Phase II study) |
| Countries | China |
| Conditions | Hepatocellular carcinoma |
| Interventions | Treatment group:Immunotherapy |
| Registration date | Jul 6, 2015 |
| Target size | Treatment group:30 |
| Registry page | chictr.org.cn |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: